Results 11 to 20 of about 116,982 (279)

Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer [PDF]

Cell Communication and Signaling, 2022
Cytokine-induced killer (CIK) cell therapy is a type of adoptive immunotherapy that due to its high proliferation rate and anti-tumor characteristics, is being investigated to treat various solid tumors.
Farimah Fayyaz, Niloufar Yazdanpanah, Nima Rezaei   +2 more
doaj   +4 more sources

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer [PDF]

BMC Cancer, 2020
Background This study aimed to investigate the efficacy and safety of cytokine-induced killer (CIK)/dendritic cell combined with CIK (DC–CIK) cell therapy in advanced gastrointestinal cancer (GIC).
Hansong Du, Jia Yang, Ying Zhang
doaj   +3 more sources

Cytokine-induced killer cells: A novel treatment for allergic airway inflammation. [PDF]

PLoS ONE, 2017
The effectiveness of cytokine-induced killer (CIK) cells for treatment of cancers has long been appreciated. Here, we report for the first time that CIK cells can be applied to treat allergic airway inflammation.
Panwadee Pluangnooch, Sunita Timalsena, Adisak Wongkajornsilp, Kitipong Soontrapa   +3 more
doaj   +5 more sources

Cytokine-induced killer cells are type II natural killer T cells

GMS German Medical Science, 2007
Background: Until now, cytokine-induced killer (CIK) cells were assumed to be part of the type I natural killer T (NKT) cell population, but it was not yet investigated if this is correct.
Schmidt-Wolf, Ingo G.H., Strehl, John, Frank, Susanne, Gütgemann, Stefan   +3 more
doaj   +3 more sources

Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. [PDF]

J Immunother Cancer, 2023
Li CMY, Tomita Y, Dhakal B, Li R, Li J, Drew P, Price T, Smith E, Maddern GJ, Fenix KA.   +9 more
europepmc   +3 more sources

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors [PDF]

Journal of Cancer, 2011
Cytokine-induced killer (CIK) cells are a heterogeneous subset of ex-vivo expanded T lymphocytes which present a mixed T-NK phenotype and are endowed with a MHC-unrestricted antitumor activity. The main functional properties of CIK cells may address some
Dario Sangiolo
doaj   +3 more sources

Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab [PDF]

Antibodies
Strategies to increase the anti-tumor efficacy of cytokine-induced killer cells (CIKs) include genetic modification with chimeric antigen receptors (CARs) or the addition of soluble T-cell engaging bispecific antibodies (BsAbs).
Silvia Zaninelli, Silvia Panna, Sarah Tettamanti, Giusi Melita, Andrea Doni, Francesca D’Autilia, Rut Valgardsdottir, Elisa Gotti, Alessandro Rambaldi, Josée Golay, Martino Introna   +10 more
doaj   +2 more sources

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer. [PDF]

Pathol Oncol Res, 2023
Sun J, Sun Y, Miniderima, Wang X.
europepmc   +3 more sources

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma. [PDF]

Int J Mol Sci, 2023
Ge F, Wang Y, Sharma A, Yang Y, Liu H, Essler M, Jaehde U, Schmidt-Wolf IGH.   +7 more
europepmc   +3 more sources

Presence of the Transmembrane Protein Neuropilin in Cytokine-induced Killer Cells [PDF]

Anticancer Research, 2020
Cytokine-induced killer (CIK) cells are a heterogenous population of immune cells showing promising applications in immunotherapeutic cancer treatment. Neuropilin (NRP) proteins have been proven to play an important role in cancer development and prognosis.
EUGENIA V. DÍEZ GARCÍA DE OLALLA, Francesca Garofano, Hans Weiher, Michael H. Muders, Sarah Förster, Ingo G.H. Schmidt‐Wolf   +5 more
openalex   +4 more sources